Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.11, moving +1.63% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.11%.

Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 174.14M to 173.93M. This put 35.4% of the company's publicly available shares ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Health Discovery Corp. is a pattern recognition company, which engages in mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United ...

Health Discovery Corp. is a pattern recognition company, which engages in mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Every time you type a web address into your browser, a quiet transaction happens before the page ever loads. Your device asks ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

How doors, keys, and backtracking unlocked survival horror.

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...